Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment

Irene Roman Dégano; Rafel Ramos; Maria García-Gil; Alberto Zamora; Marc Comas-Cufí; Albert Francés; Anna Garcia-Elias; Jaume Marrugat

doi:10.1177/2047487319862103

Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment

Eur J Prev Cardiol. 2020 Dec;27(19):2102-2104. doi: 10.1177/2047487319862103. Epub 2019 Jul 9.

Authors

Irene Roman Dégano^{1

2

3}, Rafel Ramos^{4

5

6

7}, Maria García-Gil⁴, Alberto Zamora^{6

8}, Marc Comas-Cufí⁴, Albert Francés^{1

3

9}, Anna Garcia-Elias¹⁰, Jaume Marrugat^{1

3}

Affiliations

¹ REGICOR Study Group, IMIM (Hospital del Mar Medical Research Institute), Spain.
² Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Spain.
³ CIBERCV of Cardiovascular Diseases, Instituto de Salud Carlos III (ISCIII), Spain.
⁴ Vascular Health Research Group (ISV-Girona), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Spain.
⁵ Institut Català de la Salut, Spain.
⁶ Department of Medical Sciences, University of Girona, Spain.
⁷ Biomedical Research Institute, Institut Català de la Salut, Spain.
⁸ Lipid and Atherosclerosis Unit and Department of Internal Medicine, Hospital de Blanes, Spain.
⁹ Hospital del Mar, Spain.
¹⁰ Group of Biomedical Research in Heart Diseases, IMIM, Spain.

PMID: 31288537
DOI: 10.1177/2047487319862103

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Cardiovascular Diseases / blood*
Cardiovascular Diseases / mortality*
Cause of Death
Cholesterol, LDL / blood*
Female
Humans
Hypolipidemic Agents
Incidence
Male
Middle Aged
Peripheral Vascular Diseases / blood*
Peripheral Vascular Diseases / mortality*
Risk Factors
Spain / epidemiology

Substances

Cholesterol, LDL
Hypolipidemic Agents